-
-
-
-
-
-
-
Chembio’s CEO Letter to Stockholders
-
-
-
-
-
-
-
Chembio Diagnostics (CEMI) Appoints Leslie Teso-Lichtman to its Board
-
-
-
-
-
-
-
Chembio Diagnostics Reports First Quarter 2021 Financial Results
-
-
-
-
-
-
-
Chembio Diagnostics Reports Fourth Quarter and Full Year 2019 Financial Results
-
-
-
-
-
-
-
Chembio Diagnostics Enters into Definitive Agreement to Acquire Orangelife
-
-
-
-
-
-
-
Chembio Diagnostics (CEMI) Prices 2.37M Share Common Stock Offering at $6.75/Each
-
-
-
-
-
-
-
Chembio Reports Preliminary Third Quarter 2018 Revenue
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

